Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA's Nasacort Allergy 24HR Approved by FDA for Over-the-Counter Use


Friday, 11 Oct 2013 02:30pm EDT 

Sanofi SA announced that the United States Food and Drug Administration (FDA) approved Nasacort Allergy 24HR nasal spray as an over-the-counter (OTC) treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older. Nasacort will be marketed by Sanofi’ SAs consumer healthcare division in the United States, Chattem, Inc. 

Company Quote

79.75
0.13 +0.16%
19 Aug 2014